Related Practice Life Sciences & Pharma Immuno-oncology has significant diagnostic needs including identifying patients most likely to respond to therapies. 08012019170843
Special Report Business Services Look Forward 2026: Strategic Priorities for Creating Value February 11, 2026
Published Articles Life Sciences & Pharma Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton January 14, 2026
Executive Insights Life Sciences & Pharma Indonesia’s Retail Pharmacy Landscape: Why Global Investors Should Take a Closer Look October 16, 2025
Video / Webinar Life Sciences & Pharma Navigating China's Volume-Based Procurement in the Pharma Industry August 27, 2025
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (China) July 22, 2025
Executive Insights Life Sciences & Pharma Is Biopharma Doing Enough to Advance Novel Targets? May 15, 2025
